Robust planning is the key to commercial success of a product. At MedDx, we support clients in developing a robust growth strategy through.
Indication or asset prioritization and identifying the ones to pursue for development and commercialization
Supporting go/no-go decisions.
Development of life cycle management (LCM) strategies to help compete with aggressive generic competition while maintaining a greater market cap post-patent-expiry.